rilzabrutinib (CHEBI:755717)

CHEBI:755717 - rilzabrutinib

Formula	C36H40FN9O3
Net Charge	0
Average Mass	665.774
Monoisotopic Mass	665.32381
SMILES	CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1
InChI	InChI=1S/C36H40FN9O3/c1-36(2,45-15-13-43(14-16-45)26-21-48-22-26)18-24(19-38)35(47)44-12-6-7-25(20-44)46-34-31(33(39)40-23-41-34)32(42-46)29-11-10-28(17-30(29)37)49-27-8-4-3-5-9-27/h3-5,8-11,17-18,23,25-26H,6-7,12-16,20-22H2,1-2H3,(H2,39,40,41)/b24-18+/t25-/m1/s1
InChIKey	LCFFREMLXLZNHE-GBOLQPHISA-N

Roles Classification

dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin.

anti-asthmatic agent Any compound that has anti-asthmatic effects.

anti-inflammatory agent Any compound that has anti-inflammatory effects.

anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood.

ChEBI Ontology

Outgoing Relation(s)
	rilzabrutinib (CHEBI:755717) has role anti-anaemic agent (CHEBI:75835)
	rilzabrutinib (CHEBI:755717) has role anti-asthmatic agent (CHEBI:65023)
	rilzabrutinib (CHEBI:755717) has role anti-inflammatory agent (CHEBI:67079)
	rilzabrutinib (CHEBI:755717) has role dermatologic drug (CHEBI:50177)
	rilzabrutinib (CHEBI:755717) is a aromatic ether (CHEBI:35618)

INN	Source
rilzabrutinib	WHO MedNet

Citations